Research institute
New microfluidic process enables researchers to create unique environment for developing medicine that cannot be achieved through conventional methods, paving the way for more potent, high-quality drugs
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
Researchers with City of Hope have developed a chimeric antigen receptor (CAR) T cell therapy leveraging chlorotoxin, a component of scorpion venom.
A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.
It will combine MPM’s venture capital investment fundraising with Dana-Farber’s philanthropic fundraising for cancer research.
Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020.
Study points to strategies for improving outcomes with immunotherapy in rare cancer type
Small cell lung cancer accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes.
Parkinson’s disease affects the brain’s nerve cells that produce dopamine. Researchers at the University of Helsinki have identified a molecule called BT13 that potentially can increase levels of dopamine.
Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?
PRESS RELEASES